About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Sphkaptm1.1Nina
targeted mutation 1.1, Nobuya Inagaki
MGI:6449058
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Sphkaptm1.1Nina/Sphkaptm1.1Nina Not Specified MGI:6473655


Genotype
MGI:6473655
hm1
Allelic
Composition
Sphkaptm1.1Nina/Sphkaptm1.1Nina
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Sphkaptm1.1Nina mutation (0 available); any Sphkap mutation (87 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• glucose-stimulated insulin secretion (GSIS) at high (16.7 mM) glucose concentration in the presence of 10 nM exendin-4 is similar to that in the absence of exendin-4 indicating that exendin-4 enhanced insulin secretion is absent in mutant islets, unlike in wild-type islets where exendin-4 induces a 2.0-fold increase in GSIS at 16.7 mM glucose
• GSIS in pancreatic islets is increased by ~5.5-fold and 14.4-fold at 11.1 mM and 16.7 mM glucose, respectively, relative to that at 2.8 mM glucose, whereas GSIS is increased by ~3.2-fold and 7.3-fold, respectively, in wild-type mice
• GSIS is ~2.5-fold higher than that in wild-type mice under high glucose (11.1 mM and 16.7 mM) conditions, with no differences in islet insulin content
• sphingosine kinase activity is normal at 2.8 mM and 16.7 mM glucose and ATP and cAMP content are similarly increased in mutant and wild-type islets
• depolarization-evoked, PKA and cAMP-mediated insulin secretion are unaffected
• GSIS is similarly augmented by IBMX (a non-selective phosphodiesterase (PDE) inhibitor) in mutant and wild-type islets
• under a 2 g/kg body weight intraperitoneal glucose tolerance test (IpGTT), blood glucose levels are significantly lower than those in wild-type mice at 30 and 60 min, and tend to be even lower at 120 min; blood glucose area under the curve is reduced by 15%
• under a 2 g/kg body weight IpGTT, plasma insulin levels in the presence of 10 nM exendin-4 are significantly lower at 10 and 15 min than those in wild-type mice, while insulin-AUC is similar to that in wild-type mice at 0-120 min
• under a 2 g/kg body weight IpGTT, plasma insulin levels are higher than those in wild-type mice at 15 and 60 min and insulin area under the curve is increased by 1.24-fold

endocrine/exocrine glands
• glucose-stimulated insulin secretion (GSIS) at high (16.7 mM) glucose concentration in the presence of 10 nM exendin-4 is similar to that in the absence of exendin-4 indicating that exendin-4 enhanced insulin secretion is absent in mutant islets, unlike in wild-type islets where exendin-4 induces a 2.0-fold increase in GSIS at 16.7 mM glucose
• GSIS is ~2.5-fold higher than that in wild-type mice under high glucose (11.1 mM and 16.7 mM) conditions, with no differences in islet insulin content
• GSIS in pancreatic islets is increased by ~5.5-fold and 14.4-fold at 11.1 mM and 16.7 mM glucose, respectively, relative to that at 2.8 mM glucose, whereas GSIS is increased by ~3.2-fold and 7.3-fold, respectively, in wild-type mice
• sphingosine kinase activity is normal at 2.8 mM and 16.7 mM glucose and ATP and cAMP content are similarly increased in mutant and wild-type islets
• depolarization-evoked, PKA and cAMP-mediated insulin secretion are unaffected
• GSIS is similarly augmented by IBMX (a non-selective phosphodiesterase (PDE) inhibitor) in mutant and wild-type islets





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory